The global market for vascular closure devices (VCDs), which are often used following arterial puncture for cardiac catheterizations and other procedures, was valued at $706 million in 2013. As analyzed in a new report by Life Science Intelligence, the use of these devices, which include implantables as well as external compression products, will be strongly influenced by regional and global trends toward the implementation of cost-effective care as well as the rising use of transradial access-factors which are expected to restrain growth in the market for VCDs at the high end of the price range. This report analyzes and quantifies the key forces driving the global market for VCDs in the U.S., Europe, Asia-Pacific and the rest of the world for the period 2012-2019; some of the major issues covered in the report include:
• Trends in arterial access as well as the use of manual compression for site closure;
• Competitive factors and product introductions;
• Procedure volumes;
• Critical infrastructure and market metrics; and
• Quantitative factors including units, pricing, and product sales.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
